Last updated: September 14, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
ketamine/midazolam
Ketofol
Clinical Study ID
NCT06010927
MS-92-2023
Ages 3-10 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ASA physical status I or II
- Children scheduled for AT under general anesthesia (GA).
Exclusion
Exclusion Criteria:
- Congenital cardiovascular anomalies
- Behavioral changes
- Delayed physical development
- Children receiving sedatives or anticonvulsants therapy
Study Design
Total Participants: 140
Treatment Group(s): 2
Primary Treatment: ketamine/midazolam
Phase: 4
Study Start date:
August 25, 2023
Estimated Completion Date:
December 31, 2023
Connect with a study center
Abeer Ahmed
Maadi, Cairo 11562
EgyptActive - Recruiting
Anesthesia department - Faculty of medicine- Cairo University
Cairo,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.